Colorectal Cancer Awareness Month 2020
Thursday, February 27, 2020 - 08:00am
Meet Karen
March is Colorectal Cancer Awareness Month, and Pfizer is working to raise awareness of metastatic colorectal cancer and the importance of biomarker testing.
Only four months after her husband passed away from cancer, Karen was diagnosed with colorectal cancer. Karen had been previously misdiagnosed before her doctors decided to do a colonoscopy, and following that, she found out she had rectal cancer.
Shortly after her diagnosis, Karen underwent biomarker testing. Tests revealed that she had a specific type of mutant colorectal cancer, which typically results in a poor prognosis.
Click on the video below to hear Karen discuss her diagnosis with metastatic colorectal cancer and the importance of biomarker testing.
Recent Updates and Statements
06.27.2024 Autoimmune Diseases Diseases & Conditions Partnerships Research Opportunities to Drive Change in Alopecia Areata 06.24.2024 Employees Partnerships Pfizer Culture Responsibility Pfizer Launches 175 Days of Good—A Global Commitment to Community Volunteerism 06.12.2024 Diversity & Inclusion Employees Pfizer’s Global Asian Alliance Colleague Resource Group Celebrates Asian American Native Hawaiian Pacific Islander (AANHPI) Heritage Month 06.11.2024 Diversity & Inclusion Pfizer Culture 2024 Pride Journal—Together in Pride 06.05.2024 Albert Bourla Cancer Clinical Trials Finance Leadership May Social Media Round-Up—Clinicals Trials Day, the TIME 100, and the Future of Cancer Care
Off